Cargando…
GOS Ameliorates Nonalcoholic Fatty Liver Disease Induced by High Fat and High Sugar Diet through Lipid Metabolism and Intestinal Microbes
The treatment of nonalcoholic fatty liver disease (NAFLD) remains very challenging. This study investigated the therapeutic effect of galactose oligosaccharide (GOS), an important prebiotic, on NAFLD through in vivo and in vitro experiments and preliminarily explored the mechanism by which GOS impro...
Autores principales: | Qiu, Shuting, Chen, Jiajia, Bai, Yan, He, Jincan, Cao, Hua, Che, Qishi, Guo, Jiao, Su, Zhengquan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9268751/ https://www.ncbi.nlm.nih.gov/pubmed/35807929 http://dx.doi.org/10.3390/nu14132749 |
Ejemplares similares
-
Marine Chitooligosaccharide Alters Intestinal Flora Structure and Regulates Hepatic Inflammatory Response to Influence Nonalcoholic Fatty Liver Disease
por: Feng, Jiayao, et al.
Publicado: (2022) -
Glucosamine Improves Non-Alcoholic Fatty Liver Disease Induced by High-Fat and High-Sugar Diet through Regulating Intestinal Barrier Function, Liver Inflammation, and Lipid Metabolism
por: Li, Feng, et al.
Publicado: (2023) -
The Ameliorative Effect of COST on Diet-Induced Lipid Metabolism Disorders by Regulating Intestinal Microbiota
por: You, Huimin, et al.
Publicado: (2022) -
The Therapeutic Effect of SCFA-Mediated Regulation of the Intestinal Environment on Obesity
por: You, Huimin, et al.
Publicado: (2022) -
Biodegradation and Prospect of Polysaccharide from Crustaceans
por: Qiu, Shuting, et al.
Publicado: (2022)